ENTERA BIO LTD (ENTX)
IL0011429839 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -8.89M | -13.07M | -12.19M | -11.22M | -10.80M | |||
| Depreciation Amortization | 56.00K | 60.00K | 50.00K | 60.00K | 240.00K | |||
| Income Taxes - Deferred | 29.00K | 170.00K | -220.00K | 0.00 | N/A | |||
| Change In Working Capital | -195.00K | -1.84M | 1.41M | -350.00K | 720.00K | |||
| Interest Paid | 18.00K | N/A | N/A | 40.00K | 60.00K | |||
| Taxes Paid | 0.00 | 170.00K | 0.00 | N/A | -80.00K | |||
| Other non cash items | 1.69M | 2.17M | 1.88M | 950.00K | 920.00K | |||
| OPERATING CASH FLOW | -7.31M | -12.50M | -9.06M | -10.56M | -8.92M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -17.00K | -50.00K | -20.00K | -50.00K | -40.00K | |||
| Other Investing Activity | 0.00 | -60.00K | N/A | -30.00K | 3.99M | |||
| INVESTING CASH FLOW | -17.00K | -100.00K | -20.00K | -50.00K | 3.95M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | -140.00K | -110.00K | |||
| Stock Issued/Repurchased | 6.62M | 10.00K | 25.38M | 4.05M | 12.77M | |||
| Other Financing Activity | -580.00K | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 6.04M | 10.00K | 25.38M | 4.05M | 12.65M | |||
| Exchange Rate Effect | N/A | N/A | N/A | N/A | N/A | |||
| CHANGE IN CASH | -1.29M | -12.59M | 16.30M | -6.56M | 7.68M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -7.31M | -12.50M | -9.06M | -10.56M | -8.92M | |||
| Capital Expenditure | -17.00K | -50.00K | -20.00K | -50.00K | -40.00K | |||
| FREE CASH FLOW | -7.33M | -12.55M | -9.08M | -10.61M | -8.96M | |||
All data in USD